← Open Payments lookup

ABERA TESFAYE: Open Payments

NPI 1396339727 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,209 in 52 payments from 8 companies in 2025. Trend: 2023 $1,092 · 2024 $772 · 2025 $1,209

Food & beverage: $1,203Education: $7
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$376
Neurocrine BioSciences, Inc.3$173
Alkermes, Inc.10$168
E.R. Squibb & Sons, L.L.C.14$164
Otsuka America Pharmaceutical, Inc.6$157
Teva Pharmaceuticals USA, Inc.4$73
Janssen Pharmaceuticals, Inc3$62
Vanda Pharmaceuticals Inc.1$36

Products named: CAPLYTA, INGREZZA, COBENFY, ARISTADA, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, UZEDY.

Industry payments across CA — which companies pay providers there.